Hepatic expression of CCL2 in alcoholic liver disease is associated with disease severity and neutrophil infiltrates

Clinical and Experimental Immunology

Volumn 169, Issue 3, 2012, Pages 302-310

  Degre D ^a   Lemmers, A ^a   Gustot, T ^a   Ouziel, R ^a   Trepo E ^a   Demetter, P ^a   Verset, L ^a   Quertinmont, E ^a   Vercruysse, V ^a   Le Moine, O ^a   Deviere J ^a   Moreno, C ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Alcoholic hepatitis; Alcoholic liver disease; CCL2 MCP 1; Neutrophil

Indexed keywords

INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; STEROID;

ADULT; AGED; ALCOHOL LIVER DISEASE; ALLELE; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENOTYPE; HISTOLOGY; HUMAN; LIVER LEVEL; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL CHEMOTAXIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM;

ADULT; AGED; CHEMOKINE CCL2; COHORT STUDIES; FATTY LIVER, ALCOHOLIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS, ALCOHOLIC; HUMANS; INTERLEUKIN-8; LIVER; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; NEUTROPHIL INFILTRATION; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX;

EID: 84864740260     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2012.04609.x     Document Type: Article

References (29)

1. Tilg H, Day CP. Management strategies in alcoholic liver disease. Nat Clin Pract Gastroenterol Hepatol 2007; 4:24-34.
2. MacSween RN, Burt AD. Histologic spectrum of alcoholic liver disease. Semin Liver Dis 1986; 6:221-32.
3. Mathurin P, O'Grady J, Carithers RL etal. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut 2011; 60:255-60.
4. Mathurin P, Beuzin F, Louvet A etal. Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features. Aliment Pharmacol Ther 2007; 25:1047-54.
5. McClain CJ, Cohen DA. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 1989; 9:349-51.
6. Devière J, Content J, Denys C etal. Excessive in vitro bacterial lipopolisaccharide-induced production of monokines in cirrhosis. Hepatology 1990; 11:628-34.
7. Devière J, Content J, Denys C etal. High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis: correlation with IgA serum levels and lymphokines production. Clin Exp Immunol 1989; 77:221-5.
8. Dominguez M, Miquel R, Colmenero J etal. Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis. Gastroenterology 2009; 136:1639-50.
9. Afford SC, Fisher NC, Neil DA etal. Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis. J Pathol 1998; 186:82-9.
10. Marra F, Romanelli RG, Giannini C etal. Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. Hepatology 1999; 29:140-8.
11. Simpson KJ, Henderson NC, Bone-Larson CL etal. Chemokines in the pathogenesis of liver disease: so many players with poor defined roles. Clin Sci 2003; 104:47-63.
12. Bone-Larson CL, Simpson KJ, Colletti LM etal. The role of chemokines in the immunopathology of the liver. Immunol Rev 2000; 177:8-20.
13. Colmenero J, Battaler R, Sancho-Bru P etal. Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity. Gastroenterology 2007; 132:687-97.
14. Fischer NC, Neil DA, Adams DH. Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1 alpha in alcoholic liver disease. Gut 1999; 45:416-20.
15. Devalaraja MN, McClain CJ, Barve S etal. Increased monocyte MCP-1 production in acute alcoholic hepatitis. Cytokine 1999; 11:875-81.
16. Mandrekar P, Ambade A, Lim A etal. An essential role for MCP-1 in alcoholic liver injury: regulation of pro-inflammatory cytokines and hepatic steatosis. Hepatology 2011; 54:2185-97.
17. Alcoholic liver disease: morphological manifestations. Review by an international group. Lancet 1981; 1:707-11.
18. Mezey E. Treatment of alcoholic liver disease. Semin Liver Dis 1993; 13:210-6.
19. Stordeur P, Poulin LF, Craciun L etal. Cytokine mRNA quantification by real-time PCR. J Immunol Methods 2002; 259:55-64.
20. Lemmers A, Moreno C, Gustot T etal. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology 2009; 49:646-57.
21. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
22. Pelletier M, Maggi L, Micheletti A etal. Evidence of a cross-talk between human neutrophils and Th17 cells. Blood 2010; 115:335-43.
23. Rovin BH, Lu L, Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 1999; 259:344-8.
24. Muhlbauer M, Bosserhoff AK, Hartmann A etal. A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. Gastroenterology 2003; 125:1085-93.
25. Herfarth H, Goke M, Hellerbrand C etal. Polymorphism of monocyte chemoattractant protein 1 in Crohn's disease. Int J Colorect Dis 2003; 18:401-5.
26. Hartl D, Krauss-Etschmann S, Koller B etal. Infiltrated neutrophils acquire novel chemokine receptor expression and chemokine responsiveness in chronic inflammatory lung diseases. J Immunol 2008; 181:8053-67.
27. Souto FO, Alves-Filho JC, Turato WM etal. Essential role of CCR2 in neutrophil tissue infiltration and multiple organ dysfunction in sepsis. Am J Respir Crit Care Med 2011; 183:234-42.
28. Gabele E, Muhlbauer M, Paulo H etal. Analysis of monocyte chemotactic protein-1 gene polymorphism in patients with spontaneous bacterial peritonitis. World J Gastroenterol 2009; 15:5558-62.
29. Papachristou GI, Sass DA, Avula H etal. Is the monocyte chemotactic protein-1 -2518 G allele a risk factor for severe acute pancreatitis. Clin Gastroenterol Hepatol 2005; 3:475-81.